Skip to content

Reduction of Altitude Acclimatization Period Through Pharmacological and Nonpharmacological Interventions

Reduction of Altitude Acclimatization Period Through Pharmacological and Nonpharmacological Interventions - RAHA (Rapid Acclimatization to High Altitude)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054458
Enrollment
300
Registered
2023-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: 1. Moderate Altitude Stay and acetazolamide : Group 1: After stay at moderate altitude (5000-7000 ft) for a minimum period of 6 - 12 months, the study participants will be inducted to

Sponsors

Defence Institute of Physiology and Allied Sciences DRDO
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy Army Volunteers

Exclusion criteria

Exclusion criteria: No prior stay at high altitude, 8 weeks before study

Design outcomes

Primary

MeasureTime frame
Acute mountain sickness Score, Heart rate, SpO2, Blood pressureTimepoint: 0,1,2,3,4,5,6,7 day

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Som Nath Singh

DIPAS, DRDO

gbhaumik.dipas@gov.in01123883063

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026